Testing Oral Semaglutide as a Treatment for Alcohol Use Disorder

A phase 2 trial evaluated oral semaglutide's effects on alcohol craving and consumption in adults with alcohol use disorder.

• Glucagon-like peptide-1 receptor agonists, such as semaglutide, are associated with reduced alcohol consumption based on preclinical and observational studies.
• The trial was double-blind and randomized, ensuring unbiased results.
• Participants were adults actively seeking treatment for alcohol use disorder.
• Effects on alcohol craving and consumption were specifically measured.

Simplified